Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Alltracel Pharmaceuticals Plc announces Nanopeutics Agreement

Abstract:
Alltracel's Nanopeutics subsidiary signs new Professional Wound Care technology development agreement with ConvaTec

Alltracel Pharmaceuticals Plc announces Nanopeutics Agreement

DUBLIN, Ireland | Posted on November 11th, 2007

Alltracel Pharmaceuticals Plc., ("Alltracel" or "the Company"), (AIM:AP.L), the
healthcare innovation group focused on oral care, wound care, cardiovascular
health and dermal health markets, today announces that its Nanopeutics
subsidiary has signed a collaborative technology development agreement with
ConvaTec, a world-leading manufacturer of ostomy and wound care products with a
25-year heritage of caring for patients.


ConvaTec has been working with Alltracel since November 2006, when the initial
primary concept development agreement was announced with a professional wound
care partner. As per the original agreement, today's new technology agreement
will be funded by ConvaTec and its successful conclusion may lead to an
exclusive royalty bearing license and supply agreement between both companies.


As part of the development work under the previous agreement, Alltracel's
healthcare services division (Alltracel Healthcare Services) was also contracted
by ConvaTec to perform laboratory testing and analysis work. The extension of
the collaboration between Alltracel and ConvaTec will also include similar
laboratory testing and analysis work by Alltracel Healthcare Services.


Alltracel's Chief Executive Officer, Tony Richardson commented:


"We are very pleased to announce our continuing collaboration with ConvaTec. Our
new agreement in the area of professional wound care product development further
supports the strength of Alltracel's development work carried out to date for
ConvaTec and we look forward to progressing the commercialisation of our
professional wound care products in 2008 and beyond. The professional wound
care area is an important market for us and we are happy to be collaborating
with a partner of ConvaTec's caliber and heritage. Alltracel's Nanospider(TM)
technology affords many possibilities in this sector and seeks to improve
product performance and assist in the treatment of many patients."


Michael J Lydon PhD, Vice President Global R&D in ConvaTec commented:


"ConvaTec acknowledges the significant commercial opportunities that
nanotechnology presents in the field of professional wound care. This agreement
recognizes our continuing commitment to develop this technology to enhance
products and offer improved wound care solutions for our patients."

####

About Alltracel
Alltracel, (AIM: AP.L) (www.alltracel.com) the Healthcare Innovation Group is
focused on taking proprietary technology from research right through to
commercialisation in the global healthcare market.

Alltracel Pharmaceuticals Plc., ("Alltracel") was founded in 1996 and is a
public company which listed on London's Alternative Investment Market in July
2001.

With corporate headquarters in Dublin, Ireland; Alltracel has a commercial
office in London, England; R&D subsidiary in the Czech Republic and
manufacturing facilities in Shenzhen, China. Alltracel also has a wide network
of research, development and manufacturing partners in Europe, Asia and North
America.

Alltracel operates via two main divisions Alltracel Healthcare Group and
Alltracel Healthcare Technologies:

Alltracel Healthcare Group is focused on the commercialisation effort behind
proven innovative technologies and services for the global healthcare market.
Alltracel Healthcare Group has a range of stake holdings, joint ventures and
wholly owned business units operating in a variety of healthcare categories
including Wound Care, Oral Care, Dermal Health and Cardiovascular Health.

- Alltracel's specialist Oral Care subsidiary Synpart Limited
(www.synpartlimited.com) with offices in the UK and Germany is the leading
contract supply and manufacturing partner for the European private label
inter-dental market and also partners with a number of leading oral care brands
internationally.

- Alltracel's specialist Nanotechnology subsidiary Nanopeutics s.r.o.
(www.nanopeutics.net) is headquartered in Liberec in the Czech Republic and is
dedicated to the commercialisation of Nanospider(TM)technology for the global
healthcare market.

- Alltracel Healthcare Services provides Scientific Research, Clinical
Trial & Development Services for Healthcare companies seeking a step up in speed
of Healthcare Innovation.

Alltracel Healthcare Technologies specialises in innovation, research,
development and the deployment of proprietary technology in the global
healthcare market. Alltracel Healthcare Technologies has established a
substantial intellectual property portfolio with patents in a number of
healthcare applications areas such as Wound Care, Oral Care, Cardiovascular
Health and Dermal Health.

ConvaTec Information

ConvaTec, a world-leading manufacturer of ostomy and wound care products with a
heritage of caring about patients, is a Bristol-Myers Squibb Company (NYSE: BMY).
Bristol-Myers Squibb is a global pharmaceutical and related health care
products company.

ConvaTec's Wound Therapeutics(TM)franchise pursues a comprehensive approach that
grounds our advanced science in the everyday realities of wound and skin care.
The company's Chronic Care franchise develops innovative products and
product-related services to help people with an ostomy get back to their
everyday activities and live their lives to the fullest. For more information
please visit www.convatec.com.

Wound Therapeutics(TM)is a trademark of ConvaTec, a Division of E.R. Squibb &
Sons, LLC

m-doc(TM)& Phytopeutics(TM)are trademarks of Alltracel Pharmaceuticals plc.

Nanospider(TM)and Nanopeutics(TM)are trademarks controlled by Nanopeutics s.r.o.

For more information, please click here

Contacts:
Dublin: Karen Muldowney
Alltracel: +353 1 235 2162


London: Deborah Scott
Financial Dynamics: +44 207 831 3113

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Announcements

GLOBALFOUNDRIES Delivers 8SW RF SOI Technology for Next-Generation Mobile and 5G Applications: Advanced 8SW 300mm SOI technology enables cost-effective, high-performance RF front-end modules for 4G LTE mobile and sub-6GHz 5G applications September 20th, 2017

GLOBALFOUNDRIES Unveils Vision and Roadmap for Next-Generation 5G Applications: Technology platforms are uniquely positioned to enable a new era of ‘connected intelligence’ with the transition to 5G September 20th, 2017

GLOBALFOUNDRIES Delivers Custom 14nm FinFET Technology for IBM Systems: Jointly developed 14HP process is world’s only technology that leverages both FinFET and SOI September 20th, 2017

GLOBALFOUNDRIES Introduces New 12nm FinFET Technology for High-Performance Applications September 20th, 2017

Patents/IP/Tech Transfer/Licensing

Nanoparticles limit damage in spinal cord injury: Injection after an injury reduces inflammation and scarring September 6th, 2017

More durable, less expensive fuel cells: University of Delaware researchers have developed a new technology that could speed up the commercialization of fuel cell vehicles September 5th, 2017

Argonne National Laboratory’s Continuous ALD Technology Licensed Exclusively to Forge Nano July 7th, 2017

Aculon Expands NanoProof® Product Line for Electronics Waterproofing Technology: With growing market opportunities Aculon Launches NanoProof® 8 with Push Through Connectivity™ and NanoProof® DAB a syringe application May 30th, 2017

Alliances/Trade associations/Partnerships/Distributorships

GLOBALFOUNDRIES and Soitec Enter Into Long-term Supply Agreement on FD-SOI Wafers: Strategic milestone to help guarantee a secure, high-volume supply of FD-SOI technology September 20th, 2017

GLOBALFOUNDRIES Unveils Vision and Roadmap for Next-Generation 5G Applications: Technology platforms are uniquely positioned to enable a new era of ‘connected intelligence’ with the transition to 5G September 20th, 2017

Leti and Partners in PiezoMAT Project Develop New Fingerprint Technology for Highly Reliable Security and ID Applications: Ultra-high Resolution Pressure Sensing Uses Matrices of Vertical Piezoelectric Nanowire To Reconstruct the Smallest Features of Human Fingerprints September 5th, 2017

Phenom-World selects Deben to supply a tensile stage as an accessory to their range of desktop SEMs August 29th, 2017

Research partnerships

GLOBALFOUNDRIES Delivers Custom 14nm FinFET Technology for IBM Systems: Jointly developed 14HP process is world’s only technology that leverages both FinFET and SOI September 20th, 2017

Solar-to-fuel system recycles CO2 to make ethanol and ethylene: Berkeley Lab advance is first demonstration of efficient, light-powered production of fuel via artificial photosynthesis September 19th, 2017

A new approach to ultrafast light pulses: Unusual fluorescent materials could be used for rapid light-based communications systems September 19th, 2017

New insights into nanocrystal growth in liquid: Understanding process that creates complex crystals important for energy applications September 14th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project